Upstream Bio UPB Q1 2026 Earnings NarrowerthanExpected Loss with No Revenue Yet MTA Q1 2026 Earnings EPS Misses Estimates as Stock Rises on Broader Sentiment DAWN Q4 2025 Earnings Miss on EPS as PreRevenue Biotech Invests in Pipeline BHP Q1 2026 Earnings EPS Misses Estimates Yet Stock Gains on Operational Resilience LZM Q2 2024 Earnings EPS Misses Estimates Shares Rise 876 Niagen Bioscience Inc NAGE Q1 2026 Earnings EPS Beats Estimates by 086 but Stock Declines 343